Deferiprone and hepatic fibrosis.
暂无分享,去创建一个
[1] R. Galanello,et al. Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia. , 2002, Blood.
[2] D. Pennell,et al. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia , 2002, The Lancet.
[3] G. D’Amico,et al. Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial. , 2002, Blood cells, molecules & diseases.
[4] K. Fleming,et al. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. , 1998, The New England journal of medicine.
[5] C. Jacquelinet,et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. , 1992, Gastroenterology.
[6] G. Brittenham,et al. Assessment of bone marrow and body iron stores: old techniques and new technologies. , 1981, Seminars in hematology.